Accelerate Diagnostics, Inc. (0H8E.L)
USD 0.57
(-14.24%)
USD 0.57
(-14.24%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 24.69 Million USD | -36.48% |
| 2022 | 42.63 Million USD | -40.13% |
| 2021 | 71.21 Million USD | -37.64% |
| 2020 | 114.2 Million USD | 56.32% |
| 2019 | 73.05 Million USD | 35.76% |
| 2018 | 53.81 Million USD | 288.73% |
| 2017 | -28.51 Million USD | -48.17% |
| 2016 | -19.24 Million USD | 84.04% |
| 2015 | -120.57 Million USD | -125.16% |
| 2014 | -53.55 Million USD | -78.33% |
| 2013 | -30.02 Million USD | -148.82% |
| 2012 | -12.06 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 25.8 Million USD | -4.7% |
| 2024 Q2 | 32.47 Million USD | 31.05% |
| 2023 FY | 27.08 Million USD | -36.48% |
| 2023 Q4 | 27.08 Million USD | 65.05% |
| 2023 Q3 | 16.4 Million USD | 125.14% |
| 2023 Q1 | 48.62 Million USD | 14.05% |
| 2023 Q2 | 7.28 Million USD | -85.01% |
| 2022 Q4 | 42.63 Million USD | 12.44% |
| 2022 Q1 | 104.59 Million USD | 46.87% |
| 2022 Q2 | 106.39 Million USD | 1.72% |
| 2022 Q3 | 37.91 Million USD | -64.36% |
| 2022 FY | 42.63 Million USD | -40.13% |
| 2021 FY | 71.21 Million USD | -37.64% |
| 2021 Q1 | 110.16 Million USD | -3.11% |
| 2021 Q2 | 111.32 Million USD | 1.05% |
| 2021 Q3 | 77.99 Million USD | -29.94% |
| 2021 Q4 | 71.21 Million USD | -8.69% |
| 2020 Q2 | 96.25 Million USD | -0.45% |
| 2020 Q1 | 96.69 Million USD | 33.18% |
| 2020 Q3 | 120.04 Million USD | 24.71% |
| 2020 Q4 | 113.7 Million USD | -5.28% |
| 2020 FY | 114.2 Million USD | 56.32% |
| 2019 Q1 | 47.39 Million USD | -11.93% |
| 2019 Q4 | 72.6 Million USD | 91.25% |
| 2019 FY | 73.05 Million USD | 35.76% |
| 2019 Q3 | 37.96 Million USD | 0.91% |
| 2019 Q2 | 37.62 Million USD | -20.62% |
| 2018 FY | 53.81 Million USD | 288.73% |
| 2018 Q4 | 53.81 Million USD | -4.13% |
| 2018 Q3 | 56.13 Million USD | 15.29% |
| 2018 Q2 | 48.68 Million USD | 275.87% |
| 2018 Q1 | -27.68 Million USD | 2.9% |
| 2017 FY | -28.51 Million USD | -48.17% |
| 2017 Q3 | -34.43 Million USD | 45.01% |
| 2017 Q1 | -9.91 Million USD | 48.47% |
| 2017 Q4 | -28.51 Million USD | 17.19% |
| 2017 Q2 | -62.6 Million USD | -531.33% |
| 2016 Q1 | -72.03 Million USD | 40.26% |
| 2016 FY | -19.24 Million USD | 84.04% |
| 2016 Q4 | -19.24 Million USD | 33.02% |
| 2016 Q3 | -28.73 Million USD | 23.42% |
| 2016 Q2 | -37.51 Million USD | 47.91% |
| 2015 Q2 | -35.23 Million USD | 25.66% |
| 2015 Q1 | -47.39 Million USD | 11.5% |
| 2015 FY | -120.57 Million USD | -125.16% |
| 2015 Q4 | -120.58 Million USD | -378.68% |
| 2015 Q3 | -25.19 Million USD | 28.5% |
| 2014 Q1 | -26.01 Million USD | 13.36% |
| 2014 Q4 | -53.55 Million USD | 7.35% |
| 2014 FY | -53.55 Million USD | -78.33% |
| 2014 Q3 | -57.8 Million USD | 11.25% |
| 2014 Q2 | -65.12 Million USD | -150.31% |
| 2013 Q4 | -30.02 Million USD | 10.24% |
| 2013 Q2 | -27.17 Million USD | 7.12% |
| 2013 Q1 | -29.25 Million USD | -142.42% |
| 2013 FY | -30.02 Million USD | -148.82% |
| 2013 Q3 | -33.45 Million USD | -23.11% |
| 2012 FY | -12.06 Million USD | 0.0% |
| 2012 Q4 | -12.06 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| QuidelOrtho Corporation | 2.49 Billion USD | 99.011% |